newsfilter
← Latest News
Business Wire·

Immunome to Acquire Antibody-Related Assets and Materials from Atreca

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that it entered into a definitive asset purchase agreement with